Elite Pharmaceuticals Inc (ELTP)
0.1356
+0.01
(+7.41%)
USD |
OTCM |
May 10, 15:59
Elite Pharmaceuticals Price to Book Value: 2.974 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.768 |
| May 08, 2024 | 2.895 |
| May 07, 2024 | 2.960 |
| May 06, 2024 | 3.147 |
| May 03, 2024 | 2.846 |
| May 02, 2024 | 2.833 |
| May 01, 2024 | 2.832 |
| April 30, 2024 | 2.844 |
| April 29, 2024 | 2.960 |
| April 26, 2024 | 2.906 |
| April 25, 2024 | 2.840 |
| April 24, 2024 | 2.770 |
| April 23, 2024 | 2.702 |
| April 22, 2024 | 2.789 |
| April 19, 2024 | 2.851 |
| April 18, 2024 | 2.927 |
| April 17, 2024 | 2.978 |
| April 16, 2024 | 2.966 |
| April 15, 2024 | 2.960 |
| April 12, 2024 | 3.07 |
| April 11, 2024 | 3.067 |
| April 10, 2024 | 3.085 |
| April 09, 2024 | 3.091 |
| April 08, 2024 | 3.043 |
| April 05, 2024 | 3.07 |
| Date | Value |
|---|---|
| April 04, 2024 | 3.022 |
| April 03, 2024 | 3.07 |
| April 02, 2024 | 3.355 |
| April 01, 2024 | 3.355 |
| March 28, 2024 | 3.384 |
| March 27, 2024 | 3.355 |
| March 26, 2024 | 3.341 |
| March 25, 2024 | 3.329 |
| March 22, 2024 | 3.316 |
| March 21, 2024 | 3.352 |
| March 20, 2024 | 3.267 |
| March 19, 2024 | 3.116 |
| March 18, 2024 | 3.158 |
| March 15, 2024 | 3.157 |
| March 14, 2024 | 3.048 |
| March 13, 2024 | 3.037 |
| March 12, 2024 | 2.938 |
| March 11, 2024 | 3.182 |
| March 08, 2024 | 3.333 |
| March 07, 2024 | 3.377 |
| March 06, 2024 | 3.418 |
| March 05, 2024 | 3.316 |
| March 04, 2024 | 3.487 |
| March 01, 2024 | 3.653 |
| February 29, 2024 | 3.616 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9644
Minimum
Mar 14 2023
5.586
Maximum
Nov 16 2020
2.361
Average
2.000
Median
Oct 12 2021
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.774 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7084 |
| Theriva Biologics Inc | 0.1624 |
| Oragenics Inc | 5.233 |
Price to Book Value Related Metrics
| PE Ratio | 12.79 |
| PS Ratio | 2.918 |
| PEG Ratio | 0.1031 |
| Price | 0.1356 |
| Earnings Yield | 7.82% |
| Market Cap | 138.01M |
| PEGY Ratio | 0.1031 |
| Operating PE Ratio | 19.82 |
| Normalized PE Ratio | 10.03 |